|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
08247 BIOSINO BIO-TEC
Nominal 
3.200 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 83,132 | -14.117% | 184,291 | 263,069 | 289,073 | 373,071 |
| Cost of Sales | (49,930) | -14.558% | (113,370) | (154,669) | (161,708) | (226,794) |
| Gross Profit | 33,202 | -13.446% | 70,921 | 108,400 | 127,365 | 146,277 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | 42 | -30.000% | (9,337) | (19,502) | (1,303) | (194) | |
| Profit / (Loss) on Disposal | 51 | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 4,457 | 7328.333% | 95 | (416) | 12,346 | 6,534 | |
| Profit / (Loss) before Taxation | (13,417) | -40.876% | (67,249) | (59,720) | (17,613) | 18,516 | |
| Taxation | 58 | -- | 2,227 | 2,831 | (1,628) | (4,314) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 5,028 | 2.071% | 13,880 | 14,357 | 7,593 | (6,096) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (8,331) | -53.655% | (51,142) | (42,532) | (11,648) | 8,106 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 3,643 | 0.998% | 5,250 | 7,639 | 6,072 | 6,482 |
| Depreciation & Amortisation | -- | -- | 18,511 | 17,808 | 20,357 | 24,329 |
| Directors' Emoluments | -- | -- | 1,245 | 3,131 | 3,819 | 2,122 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -6.000 | -50.000% | -35.300 | -29.400 | -8.000 | 5.600 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.179) | 0.164 | (0.045) | 0.308 |
| NBV per share ($) | 0.773 | -- | 0.831 | 1.160 | 1.454 | 1.423 |
| Remarks: | Real time quote last updated: 25/08/2026 09:22 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -8,331 |
| %Change | -53.655% |
| EPS / (LPS) | RMB -0.060 |
| NBV Per Share (¥) | RMB 0.773 |